Moneycontrol

Budget 2023Budget 2023

PARTNERS

  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
  • SMC Global Securities Limited
  • SBI Life
Upcoming Event : LeapToUnicorn - mentoring, networking and fundraising for startups. Register now
Budget 2023
Budget 2023

How Donald Trump's executive orders to lower prescription drug prices will impact Indian drugmakers

Of the four orders, the one allowing the US government to pay the lowest price available in economically comparable countries for Medicare Part B drugs could particularly impact Indian companies

July 27, 2020 / 08:06 PM IST

US President Donald Trump has issued a series of executive orders to massively lower prescription drug prices and widen Americans’ access to life-saving medications, including insulin.

The American President’s latest orders are aimed more at bringing transparency and cutting the role middlemen play in the trade. At the same time, the order will have some impact on Indian generic pharmaceutical companies, especially those selling speciality and biosimilar drugs.

The orders, signed on July 25, included allowing certain drugs to be imported from Canada and ensure that the discounts negotiated by middlemen, who are known as pharmacy benefit managers, are passed on to Medicare patients. The other most radical proposal is to cap the prices of Medicare Part B drugs to the lowest price available in countries economically comparable to the US.

Medicare is a US federal health insurance programme that covers people who are above 65 years, people with permanent disabilities, and end-stage renal patients.